First Verified Cannabis Medicines Received

Cannasouth Limited (NZX:CBD) is pleased to announce that it has received its first shipment of verified cannabis medicines. Cannasouth CEO Mark Lucas says, "This accomplishment marks the end of a near two-year process since submitting product assessments with the Medicinal Cannabis Agency. "The differentiated formulations of our products will provide New Zealand patients and prescribers with new treatment options compared to existing products on the New Zealand market. We are confident these products offer patients and prescribers a point of difference to meet the treatment needs of a wider range of conditions." Navigating and establishing the supply chain for its first medicines means Cannasouth is now generating revenue from the sale of medicines in New Zealand. A list of all medicinal cannabis products that meet the New Zealand minimum quality standard can be found here: https://www.health.govt.nz/our-work/regulation-health-and-disability-system/m edicinal-cannabis-agency/medicinal-cannabis-agency-information-health-profess ionals/medicinal-cannabis-products-meet-minimum-quality-standard -ENDS- For further information visit www.cannasouth.co.nz or contact: Mark Lucas CEO / Executive Director Email: mark.lucas@cannasouth.co.nz Mobile: 021 484 649 Colin Foster CFO / Company Secretary Email: colin.foster@cannasouth.co.nz Mobile: 027 577 1498 End CA:00399915 For:CBD Type:MKTUPDTE Time:2022-10-04 10:05:19